Self-Serve Dialysis?

Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.

Read the full article » | Posted 05-10-2017

Related Articles

• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026
• HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon Posted 04-14-2026
• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026